Clinical Trials in North Carolina

Showing 15081-15100 of 17,526 trials

Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)

NCT01369030

This study will be an observational study in which patients who have been prescribed Deplin® are invited to participate in surveys regarding their experiences with Deplin®. The purpose of this study is to increase the understanding of the role of L-methylfolate among patients who are candidates for Deplin®, provide patients with personalized education and support, and contribute to the overall understanding of the needs and concerns of patients being treated for depression.

Major Depressive Disorder

Pamlab, Inc.554 participantsStarted Nov 2010

Greensboro, North Carolina, United States • Nashville, Tennessee, United States

WITHDRAWNPhase 338 miles

An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

NCT02082197

This is an open-study with a 26 week open label treatment period followed by an optional 26 week open label extension. The total treatment period will be 52 weeks.

HypogonadismTestosterone Deficiency

AbbVieStarted Mar 2014

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mesa, Arizona, United States +39 more locations

Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)

An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

Find Trials by Condition in North Carolina

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

Patient Registry Study of Berinert® in Normal Clinical Practice

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

Safety of Urate Elevation in Parkinson's Disease

Pramipexole ER vs. Placebo in Fibromyalgia

Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients

Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer

12 / 48 Week Pivotal PFT vs PBO in COPD I

Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia

Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia

Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer

Growth and Tolerance of Infants Fed Infant Formulas

Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.

Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease